BRIEF published on 06/25/2026 at 18:20, 25 days 22 hours ago Pims Technology: Towards Optimizing Cancer Treatments Oncology Personalized Medicine PIMS Technology European Presence Therapeutic Evaluation
BRIEF published on 05/07/2026 at 10:05, 2 months 14 days ago Aton Group is organizing a webinar for shareholders and investors on May 12, 2026 Shareholders Biotechnology Webinar 2025 Results Aton Group
BRIEF published on 04/28/2026 at 18:05, 2 months 22 days ago 2025 Annual Results: Aton Group Strategic Partnerships Biotechnology Business Expansion 2025 Results Aton Group
BRIEF published on 04/23/2026 at 18:05, 2 months 27 days ago B Cell Design innovates in response to the shortage of diagnostic reagents Patented Technology In Vitro Diagnostics Monoclonal Antibodies B Cell Design Aton Group
BRIEF published on 04/01/2026 at 18:05, 3 months 19 days ago Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF published on 03/11/2026 at 18:35, 4 months 9 days ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 4 months 9 days ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 4 months 9 days ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
BRIEF published on 02/18/2026 at 18:35, 5 months 2 days ago Hadrien Lanvin appointed Deputy Managing Director of the Aton Group Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 5 months 2 days ago Hadrien Lanvin Appointed Deputy CEO of Aton Group Biotechnology Strategic Growth Deputy CEO Hadrien Lanvin Aton Group
Published on 07/21/2026 at 15:00, 1 hour 33 minutes ago Four Nines Gold Begins Maiden Drill Program at Hayden Hill
Published on 07/21/2026 at 15:00, 1 hour 33 minutes ago BlackBerry SecuSUITE Secures Renewed NIAP Common Criteria Certification, Reinforcing Leadership in Sovereign Government-Grade Secure Communications
Published on 07/21/2026 at 14:55, 1 hour 38 minutes ago Vulcan Minerals Inc. - Drilling Completed at Carbonear Zinc-Lead SEDEX Project in Newfoundland
Published on 07/21/2026 at 14:30, 2 hours 3 minutes ago Sarama Completes Sale of its West Australian Gold Assets
Published on 07/21/2026 at 14:30, 2 hours 3 minutes ago Hillcrest Announces Shares for Debt Settlement
Published on 07/21/2026 at 16:05, 28 minutes ago Omio Group to acquire Rail Europe to consolidate the ground transportation landscape
Published on 07/21/2026 at 15:53, 39 minutes ago OHB Strengthens Argonaut Lunar Mission with MDA Space Landing Sensor Partnership
Published on 07/21/2026 at 15:49, 44 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/21/2026 at 15:48, 44 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 07/20/2026 at 18:20, 22 hours 13 minutes ago Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 22 hours 28 minutes ago Reporting on share buyback transactions carried out between July 8 and July 9, 2026
Published on 07/20/2026 at 17:40, 22 hours 53 minutes ago Mersen selected to supply Ford and Leapmotor with fuses for electric vehicles
Published on 07/20/2026 at 14:25, 1 day 2 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from July 13 to July 17 2026
